ACR seeks enhancements to FDA AI risk management guidance
AuntMinnie
APRIL 11, 2025
Food and Drug Administration (FDA) should ideally review manufacturers' plans for enabling clinical site-level validation of AI-enabled device software functions (AI-DSF), the American College of Radiology (ACR) recommended in comments on FDA's AI lifecycle management draft guidance. The FDA published its draft guidance January 7.
Let's personalize your content